Related Experiment Video
Updated: Mar 1, 2026
06:51
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
3.3K
PRKD2: A two-pronged kinase crucial for the tumor-supporting activity of HSP90
Ninel Azoitei1, Stefan Fröhling2, Claudia Scholl2
1Center for Internal Medicine I; Ulm University Hospital ; Ulm, Germany.
Molecular & Cellular Oncology
|June 17, 2016
Abstract:
PRKD2 plays an important role in tumor cell survival, proliferation, migration, and angiogenesis. We recently reported that cell death and impaired blood vessel formation evoked by inhibition of the HSP90 chaperone in human cancer cells of various tissue origins is mediated by destabilization of PRKD2.
Insights
Inhibiting HSP90 chaperone destabilizes PRKD2, leading to cancer cell death and reduced blood vessel formation. This highlights PRKD2 as a key mediator in HSP90 inhibitor-induced anti-cancer effects.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Protein kinase D2 (PRKD2) is crucial for tumor cell survival, proliferation, migration, and angiogenesis.
- Heat shock protein 90 (HSP90) is a molecular chaperone essential for the stability of numerous client proteins, including oncogenic proteins.
Purpose of the Study:
- To elucidate the role of PRKD2 in the anti-cancer effects of HSP90 inhibition.
- To investigate the mechanism by which HSP90 inhibition impacts PRKD2 stability and function in human cancer cells.
Main Methods:
- Utilized human cancer cell lines from various tissue origins.
- Administered HSP90 inhibitors to cancer cells.
- Assessed PRKD2 protein levels and stability.
- Evaluated cell death and angiogenesis markers.
Main Results:
- Inhibition of HSP90 chaperone destabilized PRKD2 in human cancer cells.
- Destabilization of PRKD2 mediated cell death.
- HSP90 inhibition led to impaired blood vessel formation, which was linked to PRKD2 destabilization.
Conclusions:
- PRKD2 is a critical mediator of the cytotoxic and anti-angiogenic effects induced by HSP90 inhibition.
- Targeting PRKD2 destabilization via HSP90 inhibition represents a potential therapeutic strategy for various human cancers.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
5.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.9K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:20The JAK-STAT Signaling Pathway
13.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.4K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
01:19Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K